These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 17495473

  • 1. Cognitive predictors of donepezil therapy response in Alzheimer disease.
    Saumier D, Murtha S, Bergman H, Phillips N, Whitehead V, Chertkow H.
    Dement Geriatr Cogn Disord; 2007; 24(1):28-35. PubMed ID: 17495473
    [Abstract] [Full Text] [Related]

  • 2. One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests.
    Borkowska A, Ziolkowska-Kochan M, Rybakowski JK.
    Hum Psychopharmacol; 2005 Aug; 20(6):409-14. PubMed ID: 15991260
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G.
    Arch Gerontol Geriatr Suppl; 2004 Aug; (9):297-307. PubMed ID: 15207427
    [Abstract] [Full Text] [Related]

  • 4. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C, Hansson O, Wallin AK, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2008 Aug; 26(3):203-11. PubMed ID: 18769065
    [Abstract] [Full Text] [Related]

  • 5. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E, Cloutier F, Fay S, Cook C, Robertson ML, Fisk J, Dei DW, Rockwood K.
    Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
    [Abstract] [Full Text] [Related]

  • 6. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 7. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
    Molinuevo JL, Berthier ML, Rami L.
    Arch Gerontol Geriatr; 2011 Jul 31; 52(1):18-22. PubMed ID: 19948364
    [Abstract] [Full Text] [Related]

  • 8. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I.
    Dement Geriatr Cogn Disord; 2007 Jul 31; 23(5):301-6. PubMed ID: 17356273
    [Abstract] [Full Text] [Related]

  • 9. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E, Yamamoto H, Watanabe T, Miyazaki A, Nakadate T, Kato N, Mimura M.
    Growth Horm IGF Res; 2008 Feb 31; 18(1):47-54. PubMed ID: 17714966
    [Abstract] [Full Text] [Related]

  • 10. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
    Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R.
    Dement Geriatr Cogn Disord; 2006 Feb 31; 21(5-6):353-63. PubMed ID: 16508298
    [Abstract] [Full Text] [Related]

  • 11. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK, Andreasen N, Eriksson S, Båtsman S, Nasman B, Ekdahl A, Kilander L, Grut M, Rydén M, Wallin A, Jonsson M, Olofsson H, Londos E, Wattmo C, Eriksdotter Jonhagen M, Minthon L, Swedish Alzheimer Treatment Study Group.
    Dement Geriatr Cogn Disord; 2007 Feb 31; 23(3):150-60. PubMed ID: 17312368
    [Abstract] [Full Text] [Related]

  • 12. Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis.
    Cummings J, Jones R, Wilkinson D, Lopez O, Gauthier S, Waldemar G, Zhang R, Xu Y, Sun Y, Richardson S, Mackell J.
    J Alzheimers Dis; 2010 Feb 31; 21(3):843-51. PubMed ID: 20634594
    [Abstract] [Full Text] [Related]

  • 13. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK.
    Neurology; 2009 May 05; 72(18):1555-61. PubMed ID: 19176895
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano FD, Brahe C, Masullo C.
    Dement Geriatr Cogn Disord; 2005 May 05; 20(4):254-61. PubMed ID: 16103669
    [Abstract] [Full Text] [Related]

  • 15. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T.
    J Neurol Sci; 2004 Oct 15; 225(1-2):135-41. PubMed ID: 15465097
    [Abstract] [Full Text] [Related]

  • 16. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease.
    Foldi NS, White RE, Schaefer LA.
    Int J Geriatr Psychiatry; 2005 May 15; 20(5):485-8. PubMed ID: 15852461
    [Abstract] [Full Text] [Related]

  • 17. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
    Lucchi E, Minicuci N, Magnifico F, Mondini S, Calza A, Avanzi S, Villani D, Bellelli G, Trabucchi M.
    Arch Gerontol Geriatr Suppl; 2004 May 15; (9):253-63. PubMed ID: 15207422
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD, Casali E, Neviani F, Martini E, Neri M.
    Arch Gerontol Geriatr; 2007 May 15; 44 Suppl 1():91-6. PubMed ID: 17317439
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.
    Hamberger MJ, Palmese CA, Scarmeas N, Weintraub D, Choi H, Hirsch LJ.
    Epilepsia; 2007 Jul 15; 48(7):1283-91. PubMed ID: 17484756
    [Abstract] [Full Text] [Related]

  • 20. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K, Snaedal J.
    Nord J Psychiatry; 2002 Jul 15; 56(3):201-6. PubMed ID: 12079572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.